David Hermanson

David Hermanson serves as the Director of Cell & Gene Therapy Applications at Bio-Techne, where responsibilities include managing two teams focused on demonstrating the utility of TcBuster, a non-viral transposase gene delivery tool, for CAR T and CAR NK cell manufacture and developing comprehensive workflow solutions using Bio-Techne's offerings. Previously, David held roles at BMoGen Biotechnologies as a Principal Scientist and at Poseida Therapeutics, Inc. in various capacities including Manager of Process Development and Senior Scientist, contributing significantly to CAR-T cell therapies. David's academic background includes a Doctor of Philosophy in Medicinal and Pharmaceutical Chemistry and a Bachelor of Arts in Biochemistry, both from the University of Minnesota.